P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000972748.88204.9a |
_version_ | 1797279979423137792 |
---|---|
author | Thomas D. Coates Maria Domenica Cappellini Sujit Sheth Kevin H.M. Kuo Antonio Giulio Piga Antonis Kattamis Martina Perin Frederik Lersch Jeevan K. Shetty Yinzhi Lai Wen-Ling Kuo Ali T. Taher |
author_facet | Thomas D. Coates Maria Domenica Cappellini Sujit Sheth Kevin H.M. Kuo Antonio Giulio Piga Antonis Kattamis Martina Perin Frederik Lersch Jeevan K. Shetty Yinzhi Lai Wen-Ling Kuo Ali T. Taher |
author_sort | Thomas D. Coates |
collection | DOAJ |
first_indexed | 2024-03-07T16:34:37Z |
format | Article |
id | doaj.art-8efb778ff67647b0a10b1b13d0f8fc95 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:34:37Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-8efb778ff67647b0a10b1b13d0f8fc952024-03-03T10:04:27ZengWileyHemaSphere2572-92412023-08-017e882049a10.1097/01.HS9.0000972748.88204.9a202308003-01361P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIALThomas D. Coates0Maria Domenica Cappellini1Sujit Sheth2Kevin H.M. Kuo3Antonio Giulio Piga4Antonis Kattamis5Martina Perin6Frederik Lersch7Jeevan K. Shetty8Yinzhi Lai9Wen-Ling Kuo10Ali T. Taher111 Children’s Hospital Los Angeles, Children’s Center for Cancer and Blood Diseases, Los Angeles, CA, United States3 Fondazione IRCCS Ca’ Granda Policlinico Hospital, University of Milan, Milan, Italy4 Weill Cornell Medicine, Division of Pediatric Hematology/Oncology, New York, NY, United States5 University Health Network, Division of Medical Oncology and Hematology, Department of Medicine, Toronto, ON, Canada7 University of Turin, Turin, Italy8 National and Kapodistrian University of Athens, First Department of Pediatrics, Athens, Greece9 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland9 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland9 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland10 Bristol Myers Squibb, Princeton, NJ, United States10 Bristol Myers Squibb, Princeton, NJ, United States11 American University of Beirut Medical Center, Department of Internal Medicine, Beirut, Lebanonhttp://journals.lww.com/10.1097/01.HS9.0000972748.88204.9a |
spellingShingle | Thomas D. Coates Maria Domenica Cappellini Sujit Sheth Kevin H.M. Kuo Antonio Giulio Piga Antonis Kattamis Martina Perin Frederik Lersch Jeevan K. Shetty Yinzhi Lai Wen-Ling Kuo Ali T. Taher P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL HemaSphere |
title | P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL |
title_full | P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL |
title_fullStr | P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL |
title_full_unstemmed | P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL |
title_short | P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL |
title_sort | p1466 effect of luspatercept on bone mineral density in patients with beta thalassemia enrolled in the phase 3 believe trial |
url | http://journals.lww.com/10.1097/01.HS9.0000972748.88204.9a |
work_keys_str_mv | AT thomasdcoates p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT mariadomenicacappellini p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT sujitsheth p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT kevinhmkuo p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT antoniogiuliopiga p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT antoniskattamis p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT martinaperin p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT frederiklersch p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT jeevankshetty p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT yinzhilai p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT wenlingkuo p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial AT alittaher p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial |